about
Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells.Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.G2M arrest and apoptosis in murine T lymphoma cells following exposure to 212Bi alpha particle irradiation.Accumulation of indium-111-labeled human low density lipoprotein in the rabbit aorta: Implications for nuclear imaging of vascular lesions.The development of alpha-emitting radionuclide lead 212 for the potential treatment of ovarian carcinoma.Analysis of ascites from patients with ovarian carcinoma by cell flow cytometryIncreased nuclear damage by high linear energy transfer radioisotopes applicable for radiodirected therapy against radiologic malignanciesAstatine-211 labeling of an antimelanoma antibody and its Fab fragment using N-succinimidyl p-astatobenzoate: comparisons in vivo with the p-[125I]iodobenzoyl conjugateInterlaboratory comparison of different alpha-particle and radon sources: cell survival and relative biological effectivenessModeling of dose to tumor and normal tissue from intraperitoneal radioimmunotherapy with alpha and beta emittersRadioimmunotherapy with alpha-particle-emitting immunoconjugatesThe effect of the alpha-emitting radionuclide lead-212 on human ovarian carcinoma: a potential new form of therapyTreatment of rheumatoid synovitis of the knee with intraarticular injection of dysprosium 165-ferric hydroxide macroaggregatesRadiometal labeling of immunoproteins: covalent linkage of 2-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid ligands to immunoglobulinLocalization of sarcoma xenografts in nude mice with indium-111-labeled monoclonal antibodiesA revised method for the synthesis of 1,1-bis(4-hydroxyphenyl)-2-phenylethylene (BHPE) and its derivativesProduction of 52Fe for use in a radionuclide generator systemPreparation and evaluation of para-[211At]astatobenzoyl labeled anti-renal cell carcinoma antibody A6H F(ab')2. In vivo distribution comparison with para-[125I]iodobenzoyl labeled A6H F(ab')2Comparison of sensitivities of cells to X-ray therapy, chemotherapy, and isotope therapy using a tumor spheroid modelNuclear medicine finds the right chemistryRetention of plutonium and americium by rockManaging the unmanageable
P50
Q40169970-163CA356-221F-4AB1-AA45-EF0F27A269ACQ40358976-0A846079-093D-4AAC-8088-EF42655D2914Q41535012-60BADEA2-A5B1-4D35-AB54-F496721FF03EQ54266234-04276B09-2B66-47F4-9B89-C6391A6AEBE9Q54356325-33DE22DB-657E-41A9-B6C7-81978F275D30Q67727529-E41CC0F6-516D-4EB3-B116-40AF506E4A0EQ67791781-244182A8-2050-49A5-8CFB-114623400C17Q68030808-207FD14E-BC83-4E9E-96C3-389F21863E91Q68091228-DDF79379-7F4B-437A-8F7D-604AFE065684Q68637484-2C43FB08-6C25-4D9F-9A04-AA1A86AE5442Q69918183-864F3D40-4D70-4930-9D88-A7D2915A3F05Q69936524-3F452399-23D2-4198-BD0E-05A53678AC45Q70132127-D6D23BCB-E076-48D8-9C21-5E349E174F2FQ70290393-CF47DA90-31B3-4669-9C1F-C2DAACF6BBD3Q70510265-B6B3C413-309C-4EE3-8713-ADFC5E23465BQ70691050-2767DD55-32F7-49BE-98D8-06B7F21BF2FDQ71142852-9A81D0B0-0DC0-44FE-911A-06A7831886A4Q72750873-0E9E3087-0B36-44BD-8C51-4391148A6E30Q72801777-B2F7C00E-1EC1-468E-B9C9-49A221520F78Q78203855-42234C2E-BEB8-46AC-A06F-CCE26D81C4C8Q81017089-39DBDE0C-E150-464D-8BCC-9B3C777F45B5Q84331523-18A2FD6C-A4F7-4208-83F9-535293CD002A
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
R W Atcher
@ast
R W Atcher
@en
R W Atcher
@es
R W Atcher
@nl
type
label
R W Atcher
@ast
R W Atcher
@en
R W Atcher
@es
R W Atcher
@nl
prefLabel
R W Atcher
@ast
R W Atcher
@en
R W Atcher
@es
R W Atcher
@nl
P31
P496
0000-0003-4656-2247